The United States Food and Drug Administration (USFDA) has concluded inspection at AuroPeptides, a manufacturer of Peptide APIs, a subsidiary/business arm of Aurobindo Pharma, with one observation, relating to facility and equipment maintenance. This observation does not pertain to data integrity or related GMP compliance.
The USFDA conducted inspection at AuroPeptides from August 17 to 21, 2026. AuroPeptides is located at Indrakaran Village, Sangareddy District, Telangana.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1909.90 |
| Dr. Reddys Labs. | 1194.50 |
| Cipla | 1435.00 |
| Lupin | 2190.00 |
| Zydus Lifesciences | 1101.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: